Medtronic Starts Endeavor FDA Submission
10th Oct 2005, 17:33 GMT
Medtronic said that it submitted the 1st of 4 marketing application segments to the FDA for its Endeavor drug-coated stent.
Medtronic Starts Endeavor FDA Submission related news:
- Medtronic Submits 1st PMA Module to the US FDA for Endeavor Drug-Eluting Coronary Stent — Radiology News from StratCenter.com
- Medtronic seeks US approval for drug-coated stents — Angiography/ Cardiac Cath News from StratCenter.com
- Jury Awards Medtronic $51 mln in Patent Case — Physician News News from StratCenter.com
- Medtronic Annual Institutional Investor/Analyst Update, 10/11/2005 — StratWire - Business of Healthcare NewsFeed
- Astrazeneca Submits New Drug Application to FDA For Symbicort® Maintenance Treatment Of Asthma — Medical News Today RSS/XML Feed
- Endeavor Commerce Secures Funding — PR Web (The Free Wire Service) Business e-Commerce
- Jury awards Medtronic $51M in patent case — Latest news from The Minneapolis/St. Paul Business Journal
- CollaGenex Stock Up on Oracea Application — Financial News News from StratCenter.com
- Appeals Court vacates injunction on Medtronic spinal screws — Latest news from Memphis Business Journal
- Biomet's Patent Infringement Lawsuit Against Medtronic Continues After Appellate Court Ruling — Surgery News from StratCenter.com
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease